Mitochondrion, lysosome, and endoplasmic reticulum: Which is the best target for phototherapy?

J Control Release. 2022 Nov:351:692-702. doi: 10.1016/j.jconrel.2022.09.037. Epub 2022 Oct 7.

Abstract

Photodynamic therapy (PDT) is a robust cancer treatment modality, and the precise spatiotemporal control of its subcellular action site is crucial for its effectiveness. However, accurate comparison of the efficacy of different organelle-targeted PDT approaches is challenging since it is difficult to find a single system that can achieve separate targeting of different organelles with separable time windows and similar binding amounts. Herein, we conjugated chlorin e6 (Ce6) with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethylene glycol)-5000] (ammonium salt) (DSPE-PEG5000-NH2) to afford DSPE-PEG-Ce6, which could migrate from mitochondrion to lysosome and ultimately to endoplasmic reticulum (ER) after cellular internalization. Benefiting from the dynamic subcellular distribution of DSPE-PEG-Ce6 with tunable organelle-binding amounts, we accurately determined the PDT efficacy order of the molecule, i.e., mitochondrion > ER > lysosome. This work proposes an ideal model system for accurately evaluating the specific organelle-targeted PDT efficacy and may promote the future development of effective PDT strategies.

Keywords: Chlorin e6; Fluorescence imaging/tracking; Intracellular localization; Micelle; Photodynamic therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Endoplasmic Reticulum / metabolism
  • Lysosomes / metabolism
  • Mitochondria
  • Photochemotherapy*
  • Photosensitizing Agents / chemistry
  • Phototherapy
  • Porphyrins*

Substances

  • Porphyrins
  • Photosensitizing Agents